The present invention relates to a pharmaceutical composition for the treatment, palliative care or prevention of cancer such as medullary thyroid carcinoma. Specifically, the present invention relates to a pharmaceutical composition for the treatment, palliative care or prevention of cancer such as medullary thyroid carcinoma, which contains a liposome modified with octreotide.